Riskpilot← Back to searchSign inGet full accessLEOMEDICUS AS
ASActiveOrg 998311683Gunnars Veg 87, 3746 SkienMedical specialists activities · NACE 8622Est. 20124 employees
Revenue 2024
NOK 6,8M
+12% vs 2023
EBITDA margin
46.9%
+8% vs 2023
Equity ratio
87.4%
Financial strength
Net profit 2024
NOK 2,5M
+12% vs 2023
| Revenue | NOK 6,8M | +12% |
| EBITDA | NOK 3,2M | +8% |
| Net profit | NOK 2,5M | +12% |
| Total assets | NOK 15,9M | +19% |
| Equity | NOK 13,9M | +12% |
| Employees | 4 | — |
Legal name
LEOMEDICUS AS
Org number
998311683
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
30. april 2012
Share capital
NOK 130 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Å yte spesialist legetjenester, investering i fast eiendom, forvalte verdipapirer og andre formuesgjenstander samt finansiering og annen virksomhet som står i forbindelse med dette.
Address
Gunnars Veg 87, 3746 Skien
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 3 139 | 3 736 | 4 487 | 4 717 | 4 935 | 5 668 | 4 730 | 5 045 | 5 346 | 5 896 | 6 126 | 6 844 |
| Staff expenses | −0 | −347 | −768 | −757 | −754 | −753 | −816 | −1 139 | −1 307 | −1 333 | −1 848 | −1 604 | −1 627 |
| EBITDA | −5 | 2 231 | 2 141 | 2 471 | 2 887 | 2 480 | 3 661 | 2 140 | 2 309 | 2 358 | 2 466 | 2 963 | 3 211 |
| Depreciation & amort. | −0 | −148 | −232 | −230 | −282 | −277 | −153 | −86 | −75 | −31 | −41 | −56 | −73 |
| EBIT | −5 | 2 083 | 1 909 | 2 241 | 2 604 | 2 203 | 3 507 | 2 054 | 2 233 | 2 327 | 2 426 | 2 907 | 3 137 |
| Net financials | 0 | −5 | 13 | 46 | 1 | 2 | 1 | −0 | 3 | −0 | −0 | −81 | 23 |
| Profit before tax | −5 | 2 078 | 1 922 | 2 286 | 2 605 | 2 205 | 3 509 | 2 053 | 2 236 | 2 327 | 2 426 | 2 826 | 3 160 |
| Tax | −0 | 577 | 521 | 618 | 653 | 532 | 811 | 520 | 487 | 499 | 527 | 614 | 691 |
| Net profit | −5 | 1 501 | 1 401 | 1 669 | 1 952 | 1 673 | 2 697 | 1 534 | 1 749 | 1 828 | 1 899 | 2 212 | 2 469 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 42 | 2 993 | 4 377 | 5 132 | 4 643 | 5 766 | 6 240 | 7 580 | 7 368 | 9 645 | 13 095 | 13 426 | 15 943 |
| Equity | 25 | 2 323 | 3 724 | 4 392 | 3 374 | 5 047 | 5 244 | 6 778 | 6 527 | 8 355 | 10 254 | 12 466 | 13 935 |
| Long-term debt | 0 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 750 | 0 | 0 |
| Short-term debt | 17 | 666 | 652 | 739 | 1 269 | 719 | 996 | 803 | 841 | 1 290 | 1 091 | 960 | 2 008 |
| Total debt | 17 | 670 | 653 | 739 | 1 269 | 719 | 996 | 803 | 841 | 1 290 | 2 841 | 960 | 2 008 |
EBITDA margin
46.9%
This company
15.8%
Market median
+197% vs market
20122024
Equity ratio
87.4%
This company
38.2%
Market median
+129% vs market
20122024
Return on equity
17.7%
This company
18.4%
Market median
+4% vs market
20122024
Net profit margin
36.1%
This company
8.1%
Market median
+346% vs market
20122024
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20122024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20122024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-03-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
UM Deputy Member | Deputy Member | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2012 | — | — | |
| Board of Directors | 2012 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LEOMEDICUS AS 
Tu Invest AsBoard members of LEOMEDICUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Moen | Deputy Member | 0 companies |
| Tormod Løve | Chairman | 0 companies |
| Tone Løve | Board of Directors | 0 companies |